The Right Drug
The Right Dose
Right from the Start
Covered by Medicare and Medicaid*
Cover by Medicaid in approved States*
The Right Drug
The Right Dose
Right from the Start
Drug Events
From Taking Their
Toll on Your PROFITS
…and Your Population!
Covered by Medicare and Medicaid*
Medicaid in approved States*
Driving Better Outcomes for Nursing Homes and Their Residents
- Every year nursing homes report over 350,000 adverse drug reactions (ADRs).1
- 22% of Medicare beneficiaries experience an ADR during their SNF stay, 59% of which are “likely preventable.”2
- 1 in 10 LTC residents experience an ADR within 30 days of admission.3
- ADRs increase ER admissions by as much as 42%, and 30-day hospital readmissions by up to 52%.4
- One in 10 hospital admissions in older patients today are directly caused by ADRs.5
- ADRs have been linked to skin ulcers, agitation, loss of appetite, impaired thinking, and loss of balance – causing more falls and injuries.
Request a 10-Minute Q&A Discovery Call
Given the astronomical number of deaths, ER visits, hospitalizations and suffering attributed to ADRs, it’s astonishing most doctors continue to practice the trial and error “one-size-fits-all” approach when prescribing drugs.
Save Money and Improve the Quality of Life for Your Residents
How Much are Adverse Drug Reactions COSTING Your Facility?
It is no secret: ADRs are an all-too-common reality in nursing communities. In fact, the average size facility -105 beds – experiences 135+ ADRs a year, skyrocketing labor costs and crushing facilities’ bottom-line.
ADRs represent the most clinically significant and costly medication-related problems in long-term care (LTC) communities today.
Many drugs currently available are “one size fits all,” but they don’t work the same way for everybody. More than 75% of people have genetic variations that affect how they respond to the most commonly prescribed medications.
As a result, as much as 50% of prescribed drugs can be ineffective.3 This makes ADRs a huge and costly liability for LTC organizations – not to mention the emotional toll on their population.
PGx Testing -The Safer, Healthier More PROFITABLE Solution
Medicare and Medicaid* now cover a non-invasive, pharmacogenomic (PGx) test that reduces the risk of ADRs. With a simple cheek swab, doctors can learn in advance if a drug is more likely to help or harm a patient- before he/she even consumes a drug.
Without PGx testing, doctors must put their patients through risky drug trials, costing facilities significant amounts of money – while subjecting their patients to ineffective medications and insidious side effects before finally finding a drug that works best.
Remarkably, most physicians are not up to speed with this innovative technology and unwittingly dismiss the test as a time constraint, at the patient’s and facility’s expense – thus, many people needlessly suffer from preventable ADRs.
St. Jude Children’s Hospital tests all its patients stating,
“If you knew about this genetic information and didn’t act on it, you would not be practicing good medicine.”
Benefits of PGx and Personalized Medicine
More Informed Prescribing Decisions
Saves
Staff Time
Saves
Facility Money
Reduces
ER Visits
Reduces Hospital Readmissions
Heightens CMS
Star Rating
Reduces
Pain & Suffering
Enhances Safety
Measures
Achieve Therapeutic
Benefits Sooner
Lifetime
Utility
Covered by Medicare & Medicaid*
Heightens CMS Star Rating
Reduces Pain & Suffering
Enhances Safety Measures
Achieve Therapeutic Benefits Sooner
Lifetime Utility
Covered by Medicare & Medicaid*
Leading Medical Institutions That Have Adopted PGx Testing
Benefits of PGx and Personalized Medicine
More Informed Prescribing Decisions
Saves Staff Time
Saves Facility Money
Reduces
ER Visits
Reduces Hospital Readmissions
Heightens CMS Star Rating
Reduces Pain & Suffering
Enhances Safety Measures
Achieve Therapeutic Benefits Sooner
Lifetime
Utility
Covered by Medicare & Medicaid*
Leading Medical Institutions That Have Adopted PGx Testing
Leading Medical Institutions That Have Adopted PGx Testing
St. Jude Children’s Hospital tests all its patients stating,
“If you knew about this genetic information and didn’t act on it, you would not be practicing good medicine.”
Financial Cost and Consequences
Real People- Real Cases - Real Proof - Real Cost
Marion had a PGx test 4- 2017. The good news, her DR. discontinued Metoprolol and decreased the dose of her HBP meds. The bad news, two years later, her pain DR. ignored her PGx report and prescribed 300 mg. of Tramadol. Within 24-hrs. Marion was rushed to the ER. If her pain DR. had simply glanced at her PGx report, the suffering, and expense could have avoided.
Marion W.
Mike was having trouble sleeping and was prescribed Escitalopram. After five weeks of side-effects and no relief, he got a PGx test. The report indicated Mick was a rapid metabolizer of Escitalopram. If he was PGx test first, he would have saved time and money by avoiding two ineffective Meds and he would have received relief five weeks sooner.
Mke F.
Dorothy was having piercing headaches and was prescribed Reglan 5mg, IV push, once and Toradol 15 mg. Hours later, she was having stroke like symptoms and was rushed to the ER for an MRI. Several weeks later, she was PGx tested, and learned she was a poor metabolize of Toradol. A pre-emptive PGx test could have saved the Ins. Co. thousands and avoided this catastrophic ADR.
Dorothy J.
Fiedler And Associates
- 360 Central Ave Suite 800 St. Petersburg, Fl 33701
- 727-655-0642
- 727-655-0642
